Related Experiment Videos
Biomarkers in the Management of Crohn's Disease
Reena Khanna1, Cynthia H Seow2
1Department of Medicine, Division of Gastroenterology, University of Western Ontario, London, Ontario, Canada.
Gastroenterology
|May 8, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
COMPARATIVE REAL-WORLD EFFECTIVENESS OF BIOLOGIC THERAPIES FOR PREVENTING POSTOPERATIVE ENDOSCOPIC RECURRENCE OF CROHN'S DISEASE.
The American journal of gastroenterology·2026
Nationalization of clinical care pathways for inflammatory bowel disease management in Canada.
Journal of the Canadian Association of Gastroenterology·2026
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease.
Pharmacogenetics and genomics·2026
Global burden of liver disease: 2026 update.
Gastroenterology·2026
Plasma mitochondrial-associated proteins scale with illness severity and predict outcome in suspected sepsis.
Critical care (London, England)·2026
Clinical characteristics, pathogen distribution, and in-hospital outcomes in patients with pyogenic liver abscess: A comparative analysis of diabetic versus non-diabetic patients.
The Journal of international medical research·2026
Plasma biglycan identified by DIA proteomics as a biomarker for differential diagnosis of perimesencephalic non-aneurysmal and aneurysmal subarachnoid hemorrhage.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026